<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1068</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2018-4-7.12</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>HIV, HEPATITIS AND OTHER SOCIALLY SIGNIFICANT INFECTIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ВИЧ, ГЕПАТИТЫ И ДРУГИЕ СОЦИАЛЬНО ЗНАЧИМЫЕ ИНФЕКЦИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">LOW HEPATITIS B VIRUS DNA BURDEN DOES NOT ALWAYS PROTECT FROM LIVER CANCER DEVELOPMENT</article-title><trans-title-group xml:lang="ru"><trans-title>LOW HEPATITIS B VIRUS DNA BURDEN DOES NOT ALWAYS PROTECT FROM LIVER CANCER DEVELOPMENT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pineau</surname><given-names>P.</given-names></name><address><country country="FR">France</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Unité “Organisation nucléaire et oncogenèse”, INSERM U993,&#13;
Institut Pasteur, Paris</institution></aff><aff><institution xml:lang="ru">Unité “Organisation nucléaire et oncogenèse”, INSERM U993, Institut Pasteur, Paris</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-30" publication-format="electronic"><day>30</day><month>12</month><year>2018</year></pub-date><volume>8</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><history><date date-type="received" iso-8601-date="2019-01-14"><day>14</day><month>01</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-01-14"><day>14</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Pineau P.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Pineau P.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Pineau P.</copyright-holder><copyright-holder xml:lang="ru">Pineau P.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/1068">https://iimmun.ru/iimm/article/view/1068</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list/></back></article>
